STRIDES PHARMA SCIENCE LIMITED — Capital/Financing Update 2024

Jan 30, 2024

==> picture [128 x 42] intentionally omitted <==

January 30, 2024

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051

Scrip code: STAR

Dear Madam/ Sir,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/ HO/ CFD/ CFDPoD-1/ P/ CIR/ 2023/ 123 dated July 13, 2023

This is to inform you that the Board of Directors of the Company in its meeting held today have approved providing corporate guarantee upto Rs. 350 crores on behalf of Stelis Biopharma Limited, an associate company of Strides.

Details of the said CGs are enclosed for your reference.

This is for your information and records.

Thanks & Regards,

For Strides Pharma Science Limited,

==> picture [84 x 83] intentionally omitted <==

Digitally signed by MANJULA MANJULA RAMAMURTHY RAMAMURTHY Date: 2024.01.30 13:15:56 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

Encl. As above

==> picture [479 x 53] intentionally omitted <==

==> picture [143 x 45] intentionally omitted <==

Disclosure under Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) and SEBI Circular bearing reference SEBI/ HO/ CFD/ CFD‐PoD‐1/ P/ CIR/ 2023/ 123 dated July 13, 2023

Corporate Guarantees provided by Strides Pharma Science Limited onbahalf of Stelis Biopharma Limited

1	Name of the party in whose favour Guarantee has been given	Catalyst Trusteeship Limited, Debenture Trustee
2	Whether the promoter/ promoter group/ group companies have any interest in this transaction? If yes, nature of interest and details thereof and whether the same is done at “arms length”	Stelis is an Associate Company of Strides and is an entity where Mr. Arun Kumar, Promoter of the Company, is a common director. All the transactions are at Arms'Length
3	Brief details of such guarantee viz. brief details of agreement entered (if any) including significant terms and conditions, including amount of guarantee;	Details provided below
a	Purpose of Corporate Guarantee	To secure the Non-Convertible Debentures issued by Stelis
b	Amount of Corporate Guarantee (in Rs.)	Upto Rs. 350 Crs
c	CG effective from	Strides' Board of Diectors have approved the proposal on January 30, 2024.
d	CG Valid upto	Until the NCD issued by Stelis in favour of Subscribers have been redeemed in full
4	Impact of such guarantees on listed entity	Corporate Guarantees provided by the Company will be treated as a contingent liability for the Company to the extent of Outstanding Loan.
5	Additional Information, if any	Gross Corporate Guarantee provided on behalf of Stelis as at December 31, 2023 is Rs. 510 Crs (excluding current proposal). Outstanding loan of Stelis against the above Gross CG as at December 31, 2023 is at ~Rs. 285 Crs.

==> picture [80 x 75] intentionally omitted <==